TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Takeda Pharma A/S
Closing information (x1000 DKK)
Closing information | 2022/03 | 2021/03 | 2020/03 |
Turnover | 910,058 | 1,939,231 | 1,569,593 |
Earnings before taxes | 42,721 | 913,721 | 3,311,294 |
Total assets | 622,293 | 2,017,020 | 3,802,420 |
Current assets | 556,571 | 1,951,086 | 3,677,130 |
Current liabilities | 525,597 | 952,485 | 1,061,868 |
Equity capital | 81,238 | 1,046,401 | 2,707,245 |
- share capital | 10,100 | 10,100 | 10,100 |
Employees (average) | 350 | 350 | 350 |
Financial ratios
Fiscal year | 2022/03 | 2021/03 | 2020/03 |
Solvency | 13.1% | 51.9% | 71.2% |
Turnover per employee | 2,600 | 5,541 | 4,485 |
Profit as a percentage of turnover | 4.7% | 47.1% | 211.0% |
Return on assets (ROA) | |||
Current ratio | 105.9% | 204.8% | 346.3% |
Return on equity (ROE) | 52.6% | 87.3% | 122.3% |
Change turnover | -1,029,173 | 369,638 | -1,679 |
Change turnover % | -53% | 24% | 0% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/03 | 2021/03 | 2020/03 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.